カテーテル関連尿路感染症治療の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

世界のカテーテル関連尿路感染症（CAUTI）治療市場は、治療方法の進歩、革新的な薬剤の処方、感染予防に対する意識の高まりなどを背景に、大きく成長する見通しです。ヘルスケア環境における一般的な合併症であるCAUTIには、尿道カテーテルの使用に関連する細菌感染を管理・予防するための的を絞った治療介入が必要です。

市場の洞察

CAUTI治療の市場規模は、2025年までに15億米ドルに達し、2032年までにさらに19億3,000万米ドルに拡大し、CAGR3.60%を記録すると予測されています。同市場の成長軌道は、ヘルスケア施設における尿道カテーテルの普及に伴うCAUTIの有病率の増加、および抗生物質耐性の懸念の高まりに影響されています。世界のカテーテル関連尿路感染症治療市場は、治療技術の進歩と感染予防への関心の高まりにより、大きな成長の可能性を秘めています。研究開発への戦略的投資と共同努力により、主要企業はCAUTI管理の進化する課題に取り組む態勢を整え、患者の転帰改善と市場の持続的拡大を確実なものにしています。さらに、在宅ヘルスケアと遠隔医療の台頭は、アクセスしやすく革新的な治療ソリューションの重要性を浮き彫りにし、今後数年間における変革的なヘルスケア分析への道を開くものです。

世界人口の高齢化により、尿道カテーテルと効果的な感染管理の需要が高まり、市場の成長を後押しします。革新的な抗生物質、防腐剤、耐感染性カテーテル材料の開発により、従来の治療法の課題が解決され、患者の転帰が改善されます。従来の抗生物質に対する耐性が高まっていることから、抗菌コーティングや代替薬剤の処方など、新たな治療アプローチの機会が生まれています。

当レポートでは、世界のカテーテル関連尿路感染症治療市場について調査し、市場の概要とともに、薬剤タイプ別、適応症タイプ別、流通チャネル別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場の定義とセグメンテーション
• 市場力学
• バリューチェーン分析
• ポーターのファイブフォース分析
• COVID-19の影響分析
• ウクライナ・ロシア紛争の影響
• 経済概要
• PESTLE分析

第3章 世界のカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

• 世界のカテーテル関連尿路感染症治療市場の見通し、薬剤タイプ別、金額（10億米ドル）、2019年～2032年
• 世界のカテーテル関連尿路感染症治療市場の見通し、適応症タイプ別、金額（10億米ドル）、2019年～2032年
• 世界のカテーテル関連尿路感染症治療市場の見通し、流通チャネル別、金額（10億米ドル）、2019年～2032年
• 世界のカテーテル関連尿路感染症治療市場の見通し、地域別、金額（10億米ドル）、2019年～2032年

第4章 北米のカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

第5章 欧州のカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

第6章 アジア太平洋のカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

第7章 ラテンアメリカのカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

第8章 中東・アフリカのカテーテル関連尿路感染症治療市場の見通し、2019年～2032年

第9章 競合情勢

• 流通チャネル別と適応症タイプ別のヒートマップ
• メーカー別と適応症タイプ別のヒートマップ
• 企業市場シェア分析、2024年
• 競合ダッシュボード
• 企業プロファイル
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Bayer AG
  • Johnson & Johnson
  • Novartis International AG
  • Sanofi
  • Roche Holding AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Boehringer Ingelheim
  • Daiichi Sankyo Company, Limited
  • Gilead Sciences, Inc.

第10章 付録

The global catheter-associated urinary tract infections (CAUTIs) treatment market is poised for significant growth, driven by advancements in treatment modalities, innovative drug formulations, and increasing awareness of infection prevention. CAUTIs, a prevalent complication in healthcare settings, necessitate targeted therapeutic interventions to manage and prevent bacterial infections associated with urinary catheter use.

Market Insights

The CAUTIs treatment market is expected to reach a value of $1.50 billion by 2025 and expand further to $1.93 billion by 2032, registering a compound annual growth rate (CAGR) of 3.60%. The market's growth trajectory is influenced by the increasing prevalence of CAUTIs, driven by the widespread use of urinary catheters in healthcare facilities, and the rising concern of antibiotic resistance. The global catheter-associated urinary tract infections treatment market offers significant growth potential, driven by advancements in therapeutic technologies and a growing focus on infection prevention. With strategic investments in R&D and collaborative efforts, key players are poised to address the evolving challenges of CAUTI management, ensuring improved patient outcomes and sustained market expansion. Furthermore, the rise of home healthcare and telemedicine underscores the importance of accessible and innovative treatment solutions, paving the way for a transformative healthcare Analysis in the years ahead.

Key Market Drivers

• 1. Expanding Aging Population: The aging global population increases the demand for urinary catheters and effective infection management, boosting market growth.
• 2. Advancements in Treatment Modalities: The development of innovative antibiotics, antiseptics, and infection-resistant catheter materials addresses the challenges of traditional therapies and improves patient outcomes.
• 3. Antibiotic Resistance: The rising resistance to conventional antibiotics creates opportunities for novel therapeutic approaches, including antimicrobial coatings and alternative drug formulations.

Business Opportunities

• 1. Rise in Home Healthcare and Telemedicine: The growing trend of home healthcare and remote medical services calls for patient-friendly and self-administered treatment options for CAUTIs. These approaches address the unique needs of patients outside traditional healthcare settings, providing significant market potential.
• 2. Antimicrobial Coatings for Catheters: Technological advancements in catheters with controlled-release antimicrobial coatings present lucrative revenue opportunities, addressing both prevention and treatment needs. The integration of antimicrobial technologies in catheter design minimizes bacterial colonization risks, enhancing patient safety.
• 3. Collaborative Research: Partnerships between pharmaceutical companies, healthcare providers, and research institutions drive innovation in CAUTI treatments, enhancing market dynamics. These collaborations foster the development of advanced therapeutic solutions tailored to emerging healthcare challenges.

Regional Analysis

• Europe: Dominates the market due to advanced healthcare infrastructure, robust research initiatives, and strategic collaborations that drive innovation. Regulatory support and funding for infection control further bolster Europe's market leadership.
• South Asia & Pacific: Emerges as the fastest-growing region, fueled by population expansion, increasing awareness, and evolving healthcare infrastructure. The adoption of modern healthcare practices and government-backed programs support market growth in this region.
• North America: Maintains a strong market presence owing to well-established healthcare systems and significant investment in medical research. The region's focus on technological integration enhances CAUTI treatment strategies.

Key Players

Prominent companies shaping the CAUTIs treatment market include:

• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline (GSK)
• AstraZeneca
• Bayer AG
• Johnson & Johnson
• Novartis International AG
• Sanofi
• Roche Holding AG
• Abbott Laboratories
• Bristol-Myers Squibb Company
• Astellas Pharma Inc.
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.

Market Segmentation

1. By Drug Type:

Penicillin & Combinations Quinolones Cephalosporins Aminoglycoside Antibiotics Sulphonamides Azoles and Amphotericin B Tetracycline Nitrofurantoin

2. By Indication Type:

Asymptomatic CAUTI (Bacteriuria) Symptomatic CAUTI (Bacteremic)

3. By Distribution Channel:

Hospital Pharmacies Gynecology and Urology Clinics Drug Stores Retail Pharmacies Online Drug Stores

4. By Region:

North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Catheter Associated Urinary Tract Infections Treatment Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 3.1. Global Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 3.1.1. Key Highlights
    • 3.1.1.1. Penicillin & Combinations
    • 3.1.1.2. Quinolones
    • 3.1.1.3. Caphalosporin
    • 3.1.1.4. Aminoglycoside Antibiotics
    • 3.1.1.5. Sulphonamides
    • 3.1.1.6. Azoles and Amphotericin B
    • 3.1.1.7. Tetracycline
    • 3.1.1.8. Nitrofura
• 3.2. Global Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 3.2.1. Key Highlights
    • 3.2.1.1. Asymptomatic CAUTI (Bacteriuria)
    • 3.2.1.2. Symptomatic CAUTI (Bacteremic)
• 3.3. Global Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 3.3.1. Key Highlights
    • 3.3.1.1. Hospital Pharmacies
    • 3.3.1.2. Gynaecology and Urology Clinics
    • 3.3.1.3. Drug Stores
    • 3.3.1.4. Retail Pharmacies
    • 3.3.1.5. Online Drug Stores
• 3.4. Global Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
  • 3.4.1. Key Highlights
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. Asia Pacific
    • 3.4.1.4. Latin America
    • 3.4.1.5. Middle East & Africa

4. North America Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 4.1. North America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Penicillin & Combinations
    • 4.1.1.2. Quinolones
    • 4.1.1.3. Cephalosporin
    • 4.1.1.4. Aminoglycoside Antibiotics
    • 4.1.1.5. Sulphonamides
    • 4.1.1.6. Azoles and Amphotericin B
    • 4.1.1.7. Tetracycline
    • 4.1.1.8. Nitrofura
• 4.2. North America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Asymptomatic CAUTI (Bacteriuria)
    • 4.2.1.2. Symptomatic CAUTI (Bacteremic)
• 4.3. North America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Hospital Pharmacies
    • 4.3.1.2. Gynaecology and Urology Clinics
    • 4.3.1.3. Drug Stores
    • 4.3.1.4. Retail Pharmacies
    • 4.3.1.5. Online Drug Stores
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis
• 4.4. North America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S. Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 4.4.1.2. U.S. Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 4.4.1.3. U.S. Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 4.4.1.4. Canada Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 4.4.1.5. Canada Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 4.4.1.6. Canada Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 5.1. Europe Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Penicillin & Combinations
    • 5.1.1.2. Quinolones
    • 5.1.1.3. Cephalosporin
    • 5.1.1.4. Aminoglycoside Antibiotics
    • 5.1.1.5. Sulphonamides
    • 5.1.1.6. Azoles and Amphotericin B
    • 5.1.1.7. Tetracycline
    • 5.1.1.8. Nitrofura
• 5.2. Europe Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Asymptomatic CAUTI (Bacteriuria)
    • 5.2.1.2. Symptomatic CAUTI (Bacteremic)
• 5.3. Europe Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Hospital Pharmacies
    • 5.3.1.2. Gynaecology and Urology Clinics
    • 5.3.1.3. Drug Stores
    • 5.3.1.4. Retail Pharmacies
    • 5.3.1.5. Online Drug Stores
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis
• 5.4. Europe Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 5.4.1. Key Highlights
    • 5.4.1.1. Germany Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.2. Germany Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.3. Germany Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.4. U.K. Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.5. U.K. Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.6. U.K. Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.7. France Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.8. France Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.9. France Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.10. Italy Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.11. Italy Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.12. Italy Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.13. Turkey Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.14. Turkey Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.15. Turkey Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.16. Russia Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.17. Russia Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.18. Russia Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 5.4.1.19. Rest of Europe Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.20. Rest of Europe Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.21. Rest of Europe Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 6.1. Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Penicillin & Combinations
    • 6.1.1.2. Quinolones
    • 6.1.1.3. Cephalosporin
    • 6.1.1.4. Aminoglycoside Antibiotics
    • 6.1.1.5. Sulphonamides
    • 6.1.1.6. Azoles and Amphotericin B
    • 6.1.1.7. Tetracycline
    • 6.1.1.8. Nitrofura
• 6.2. Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Asymptomatic CAUTI (Bacteriuria)
    • 6.2.1.2. Symptomatic CAUTI (Bacteremic)
• 6.3. Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Hospital Pharmacies
    • 6.3.1.2. Gynaecology and Urology Clinics
    • 6.3.1.3. Drug Stores
    • 6.3.1.4. Retail Pharmacies
    • 6.3.1.5. Online Drug Stores
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 6.4.1. Key Highlights
    • 6.4.1.1. China Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.2. China Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.3. China Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 6.4.1.4. Japan Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.5. Japan Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.6. Japan Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 6.4.1.7. South Korea Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.8. South Korea Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.9. South Korea Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 6.4.1.10. India Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.11. India Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.12. India Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 6.4.1.13. Southeast Asia Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.14. Southeast Asia Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.15. Southeast Asia Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 6.4.1.16. Rest of Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.17. Rest of Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.18. Rest of Asia Pacific Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 7.1. Latin America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Penicillin & Combinations
    • 7.1.1.2. Quinolones
    • 7.1.1.3. Cephalosporin
    • 7.1.1.4. Aminoglycoside Antibiotics
    • 7.1.1.5. Sulphonamides
    • 7.1.1.6. Azoles and Amphotericin B
    • 7.1.1.7. Tetracycline
    • 7.1.1.8. Nitrofura
• 7.2. Latin America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 7.2.1.1. Asymptomatic CAUTI (Bacteriuria)
  • 7.2.1.2. Symptomatic CAUTI (Bacteremic)
• 7.3. Latin America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Hospital Pharmacies
    • 7.3.1.2. Gynaecology and Urology Clinics
    • 7.3.1.3. Drug Stores
    • 7.3.1.4. Retail Pharmacies
    • 7.3.1.5. Online Drug Stores
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Latin America Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 7.4.1. Key Highlights
    • 7.4.1.1. Brazil Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.2. Brazil Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.3. Brazil Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 7.4.1.4. Mexico Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.5. Mexico Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.6. Mexico Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 7.4.1.7. Argentina Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.8. Argentina Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.9. Argentina Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 7.4.1.10. Rest of Latin America Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.11. Rest of Latin America Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.12. Rest of Latin America Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market Outlook, 2019 - 2032

• 8.1. Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Penicillin & Combinations
    • 8.1.1.2. Quinolones
    • 8.1.1.3. Cephalosporin
    • 8.1.1.4. Aminoglycoside Antibiotics
    • 8.1.1.5. Sulphonamides
    • 8.1.1.6. Azoles and Amphotericin B
    • 8.1.1.7. Tetracycline
    • 8.1.1.8. Nitrofura
• 8.2. Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Indication Type, Value (US$ Bn), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Asymptomatic CAUTI (Bacteriuria)
    • 8.2.1.2. Symptomatic CAUTI (Bacteremic)
• 8.3. Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Hospital Pharmacies
    • 8.3.1.2. Gynaecology and Urology Clinics
    • 8.3.1.3. Drug Stores
    • 8.3.1.4. Retail Pharmacies
    • 8.3.1.5. Online Drug Stores
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
  • 8.4.1. Key Highlights
    • 8.4.1.1. GCC Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.2. GCC Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.3. GCC Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 8.4.1.4. South Africa Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.5. South Africa Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.6. South Africa Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 8.4.1.7. Egypt Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.8. Egypt Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.9. Egypt Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 8.4.1.10. Nigeria Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.11. Nigeria Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.12. Nigeria Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
    • 8.4.1.13. Rest of Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market by Drug Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.14. Rest of Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market by Indication Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.15. Rest of Middle East & Africa Catheter Associated Urinary Tract Infections Treatment Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. By Distribution Channel vs by Indication Type Heat map
• 9.2. Manufacturer vs by Indication Type Heatmap
• 9.3. Company Market Share Analysis, 2024
• 9.4. Competitive Dashboard
• 9.5. Company Profiles
  • 9.5.1. Pfizer Inc.
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Product Portfolio
    • 9.5.1.3. Financial Overview
    • 9.5.1.4. Business Strategies and Development
  • 9.5.2. Merck & Co., Inc.
  • 9.5.3. GlaxoSmithKline (GSK)
  • 9.5.4. AstraZeneca
  • 9.5.5. Bayer AG
  • 9.5.6. Johnson & Johnson
  • 9.5.7. Novartis International AG
  • 9.5.8. Sanofi
  • 9.5.9. Roche Holding AG
  • 9.5.10. Eli Lilly and Company
  • 9.5.11. Bristol-Myers Squibb Company
  • 9.5.12. Abbott Laboratories
  • 9.5.13. Astellas Pharma Inc.
  • 9.5.14. Boehringer Ingelheim
  • 9.5.15. Daiichi Sankyo Company, Limited
  • 9.5.16. Gilead Sciences, Inc.

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations